Literature DB >> 29773349

Robot-assisted training using Hybrid Assistive Limb® for cerebral palsy.

Mayumi Matsuda1, Nobuaki Iwasaki2, Yuki Mataki3, Hirotaka Mutsuzaki4, Kenichi Yoshikawa5, Kazushi Takahashi5, Keiko Enomoto5, Kumiko Sano5, Aoi Kubota5, Tomohiro Nakayama6, Junko Nakayama6, Haruka Ohguro6, Masafumi Mizukami7, Kazuhide Tomita8.   

Abstract

PURPOSE: The Hybrid Assistive Limb® (HAL®, CYBERDYNE) is a wearable robot that provides assistance to a patient while they are walking, standing, and performing leg movements based on the wearer's intended movement. The effect of robot-assisted training using HAL® for cerebral palsy (CP) is unknown. Therefore, we assessed the effect of robot-assisted training using HAL® on patients with CP, and compared walking and gross motor abilities between pre-intervention and post-intervention.
METHODS: Six subjects with CP were included (mean age: 16.8 years; range: 13-24 years; Gross Motor Function Classification System levels II-IV: n = 1, 4, 1). Robot-assisted training using HAL® were performed 2-4 sessions per week, 20 min per session, within a 4 weeks period, 12 times in total. Outcome measures included gait speed, step length, cadence, single-leg support per gait cycle, hip and knee joint angle in stance, and swing phase per gait cycle, 6-minute walking distance (6 MD), physiological cost index (PCI), knee-extension strength, and Gross Motor Function Measure (GMFM).
RESULTS: There were significant increases in self-selected walking speed (SWS), cadence during SWS and maximum walking speed (MWS), single-leg support per gait cycle, hip joint angle in the swing phase, 6 MD, and GMFM. In contrast, gait speed during MWS, step length during SWS and MWS, hip and knee joint angle in the stance phase, knee joint angle in the swing phase, PCI, and knee-extension strength generally improved, but not significantly.
CONCLUSION: Robot-assisted training using HAL® may improve walking and gross motor abilities of patients with CP.
Copyright © 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral palsy; Gait analysis; Hybrid Assistive Limb®; Robot training

Mesh:

Year:  2018        PMID: 29773349     DOI: 10.1016/j.braindev.2018.04.004

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  6 in total

1.  Effectiveness of robotic-assisted therapy for upper extremity function in children and adolescents with cerebral palsy: a systematic review protocol.

Authors:  Sasithorn Sung-U; Badur Un Nisa; Kayano Yotsumoto; Rumi Tanemura
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

2.  Effect of the Hybrid Assistive Limb on the Gait Pattern for Cerebral Palsy.

Authors:  Yuki Mataki; Hirotaka Mutsuzaki; Hiroshi Kamada; Ryoko Takeuchi; Shogo Nakagawa; Kenichi Yoshikawa; Kazushi Takahashi; Mayumi Kuroda; Nobuaki Iwasaki; Masashi Yamazaki
Journal:  Medicina (Kaunas)       Date:  2020-12-07       Impact factor: 2.430

3.  Systematic review on wearable lower-limb exoskeletons for gait training in neuromuscular impairments.

Authors:  Antonio Rodríguez-Fernández; Joan Lobo-Prat; Josep M Font-Llagunes
Journal:  J Neuroeng Rehabil       Date:  2021-02-01       Impact factor: 4.262

4.  The Effects of Over-Ground Robot-Assisted Gait Training for Children with Ataxic Cerebral Palsy: A Case Report.

Authors:  Myungeun Yoo; Jeong Hyeon Ahn; Eun Sook Park
Journal:  Sensors (Basel)       Date:  2021-11-26       Impact factor: 3.576

5.  Overground Robot-Assisted Gait Training for Pediatric Cerebral Palsy.

Authors:  Seung Ki Kim; Dongho Park; Beomki Yoo; Dain Shim; Joong-On Choi; Tae Young Choi; Eun Sook Park
Journal:  Sensors (Basel)       Date:  2021-03-16       Impact factor: 3.576

6.  Gait training using a hybrid assistive limb after botulinum toxin treatment for cerebral palsy: a case report.

Authors:  Mayumi Matsuda Kuroda; Hirotaka Mutsuzaki; Kenichi Yoshikawa; Haruka Ohguro; Iwasaki Nobuaki
Journal:  J Phys Ther Sci       Date:  2021-06-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.